RTW INVESTMENTS, LP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$313,777,864
+1.9%
4,489,596
+4.8%
6.62%
+13.0%
Q2 2023$307,868,145
+32.0%
4,284,277
+13.3%
5.86%
+20.7%
Q1 2023$233,203,136
+1.4%
3,780,855
+26.9%
4.86%
+3.5%
Q4 2022$229,884,577
+173.7%
2,980,482
+58.4%
4.69%
+142.4%
Q3 2022$83,982,000
+35.5%
1,882,164
+16.3%
1.94%
+20.8%
Q2 2022$62,001,000
-7.5%
1,618,8190.0%1.60%
+15.5%
Q1 2022$67,003,000
+9.6%
1,618,8190.0%1.39%
+55.3%
Q4 2021$61,159,000
+14.8%
1,618,819
+0.1%
0.89%
+11.1%
Q3 2021$53,280,000
-51.1%
1,616,4970.0%0.80%
-51.2%
Q2 2021$109,049,000
+19.1%
1,616,4970.0%1.65%
+15.2%
Q1 2021$91,526,000
-32.8%
1,616,497
-3.3%
1.43%
-37.5%
Q4 2020$136,252,000
+14.4%
1,672,416
+0.1%
2.29%
-20.2%
Q3 2020$119,054,000
-12.7%
1,670,938
+0.8%
2.87%
-25.3%
Q2 2020$136,446,000
+120.3%
1,658,316
+57.5%
3.84%
+44.0%
Q1 2020$61,946,000
-41.6%
1,052,969
+2.5%
2.67%
-33.4%
Q4 2019$106,131,000
+519.7%
1,026,813
+21.4%
4.00%
+293.3%
Q3 2019$17,125,000
-21.2%
846,121
+0.2%
1.02%
-12.3%
Q2 2019$21,740,000
+156.5%
844,289
+41.7%
1.16%
+100.5%
Q1 2019$8,476,000595,6350.58%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders